img

Global Human Immunodeficiency Virus (HIV) Therapeutics Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Immunodeficiency Virus (HIV) Therapeutics Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Human Immunodeficiency Virus (HIV) Therapeutics Market
The global Human Immunodeficiency Virus (HIV) Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Human Immunodeficiency Virus (HIV) Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Human Immunodeficiency Virus (HIV) Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Human Immunodeficiency Virus (HIV) Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key companies of Human Immunodeficiency Virus (HIV) Therapeutics include ViiV Healthcare, Mylan, AbbVie, Merck & Co., Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Genentech, Inc., Cipla, Inc. and Boehringer Ingelheim GmbH, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Human Immunodeficiency Virus (HIV) Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Human Immunodeficiency Virus (HIV) Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Human Immunodeficiency Virus (HIV) Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Immunodeficiency Virus (HIV) Therapeutics revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global Human Immunodeficiency Virus (HIV) Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for Human Immunodeficiency Virus (HIV) Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including ViiV Healthcare, Mylan, AbbVie, Merck & Co., Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Genentech, Inc., Cipla, Inc. and Boehringer Ingelheim GmbH, etc.



By Company


ViiV Healthcare
Mylan
AbbVie
Merck & Co., Inc.
Bristol-Myers Squibb Company
Boehringer Ingelheim GmbH
Genentech, Inc.
Cipla, Inc.
Boehringer Ingelheim GmbH
Genentech, Inc.
Segment by Type
NRTIs
NNRTIs
Entry and Fusion Inhibitors
Protease Inhibitors
Integrase Inhibitors
Coreceptor Antagonists

Segment by Application


Hospitals
Clinics
Labs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Human Immunodeficiency Virus (HIV) Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Human Immunodeficiency Virus (HIV) Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Immunodeficiency Virus (HIV) Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 NRTIs
1.2.3 NNRTIs
1.2.4 Entry and Fusion Inhibitors
1.2.5 Protease Inhibitors
1.2.6 Integrase Inhibitors
1.2.7 Coreceptor Antagonists
1.3 Market by Application
1.3.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Labs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Perspective (2018-2034)
2.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Growth Trends by Region
2.2.1 Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Human Immunodeficiency Virus (HIV) Therapeutics Historic Market Size by Region (2018-2024)
2.2.3 Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Region (2024-2034)
2.3 Human Immunodeficiency Virus (HIV) Therapeutics Market Dynamics
2.3.1 Human Immunodeficiency Virus (HIV) Therapeutics Industry Trends
2.3.2 Human Immunodeficiency Virus (HIV) Therapeutics Market Drivers
2.3.3 Human Immunodeficiency Virus (HIV) Therapeutics Market Challenges
2.3.4 Human Immunodeficiency Virus (HIV) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Human Immunodeficiency Virus (HIV) Therapeutics by Players
3.1.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue by Players (2018-2024)
3.1.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Players (2018-2024)
3.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Human Immunodeficiency Virus (HIV) Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Concentration Ratio
3.4.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Immunodeficiency Virus (HIV) Therapeutics Revenue in 2022
3.5 Global Key Players of Human Immunodeficiency Virus (HIV) Therapeutics Head office and Area Served
3.6 Global Key Players of Human Immunodeficiency Virus (HIV) Therapeutics, Product and Application
3.7 Global Key Players of Human Immunodeficiency Virus (HIV) Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Immunodeficiency Virus (HIV) Therapeutics Breakdown Data by Type
4.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Historic Market Size by Type (2018-2024)
4.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Type (2024-2034)
5 Human Immunodeficiency Virus (HIV) Therapeutics Breakdown Data by Application
5.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Historic Market Size by Application (2018-2024)
5.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2018-2034)
6.2 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type
6.2.1 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2018-2024)
6.2.2 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2024-2034)
6.2.3 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2018-2034)
6.3 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application
6.3.1 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2018-2024)
6.3.2 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2024-2034)
6.3.3 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2018-2034)
6.4 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country
6.4.1 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2018-2024)
6.4.3 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2018-2034)
7.2 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type
7.2.1 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2018-2024)
7.2.2 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2024-2034)
7.2.3 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2018-2034)
7.3 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application
7.3.1 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2018-2024)
7.3.2 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2024-2034)
7.3.3 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2018-2034)
7.4 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country
7.4.1 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2018-2024)
7.4.3 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2018-2034)
8.2 China Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type
8.2.1 China Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2018-2024)
8.2.2 China Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2024-2034)
8.2.3 China Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2018-2034)
8.3 China Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application
8.3.1 China Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2018-2024)
8.3.2 China Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2024-2034)
8.3.3 China Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2018-2034)
9.2 Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type
9.2.1 Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2018-2024)
9.2.2 Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2024-2034)
9.2.3 Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2018-2034)
9.3 Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application
9.3.1 Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2018-2024)
9.3.2 Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2024-2034)
9.3.3 Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2018-2034)
9.4 Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region
9.4.1 Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2018-2024)
9.4.3 Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 ViiV Healthcare
11.1.1 ViiV Healthcare Company Details
11.1.2 ViiV Healthcare Business Overview
11.1.3 ViiV Healthcare Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.1.4 ViiV Healthcare Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
11.1.5 ViiV Healthcare Recent Developments
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Mylan Business Overview
11.2.3 Mylan Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.2.4 Mylan Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
11.2.5 Mylan Recent Developments
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.3.4 AbbVie Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
11.3.5 AbbVie Recent Developments
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Company Details
11.4.2 Merck & Co., Inc. Business Overview
11.4.3 Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.4.4 Merck & Co., Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
11.4.5 Merck & Co., Inc. Recent Developments
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Company Details
11.5.2 Bristol-Myers Squibb Company Business Overview
11.5.3 Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.5.4 Bristol-Myers Squibb Company Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
11.5.5 Bristol-Myers Squibb Company Recent Developments
11.6 Boehringer Ingelheim GmbH
11.6.1 Boehringer Ingelheim GmbH Company Details
11.6.2 Boehringer Ingelheim GmbH Business Overview
11.6.3 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.6.4 Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
11.6.5 Boehringer Ingelheim GmbH Recent Developments
11.7 Genentech, Inc.
11.7.1 Genentech, Inc. Company Details
11.7.2 Genentech, Inc. Business Overview
11.7.3 Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.7.4 Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
11.7.5 Genentech, Inc. Recent Developments
11.8 Cipla, Inc.
11.8.1 Cipla, Inc. Company Details
11.8.2 Cipla, Inc. Business Overview
11.8.3 Cipla, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.8.4 Cipla, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
11.8.5 Cipla, Inc. Recent Developments
11.9 Boehringer Ingelheim GmbH
11.9.1 Boehringer Ingelheim GmbH Company Details
11.9.2 Boehringer Ingelheim GmbH Business Overview
11.9.3 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.9.4 Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
11.9.5 Boehringer Ingelheim GmbH Recent Developments
11.10 Genentech, Inc.
11.10.1 Genentech, Inc. Company Details
11.10.2 Genentech, Inc. Business Overview
11.10.3 Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.10.4 Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
11.10.5 Genentech, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of NRTIs
Table 3. Key Players of NNRTIs
Table 4. Key Players of Entry and Fusion Inhibitors
Table 5. Key Players of Protease Inhibitors
Table 6. Key Players of Integrase Inhibitors
Table 7. Key Players of Coreceptor Antagonists
Table 8. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 9. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 10. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 11. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Region (2018-2024)
Table 12. Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 13. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Region (2024-2034)
Table 14. Human Immunodeficiency Virus (HIV) Therapeutics Market Trends
Table 15. Human Immunodeficiency Virus (HIV) Therapeutics Market Drivers
Table 16. Human Immunodeficiency Virus (HIV) Therapeutics Market Challenges
Table 17. Human Immunodeficiency Virus (HIV) Therapeutics Market Restraints
Table 18. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue by Players (2018-2024) & (US$ Million)
Table 19. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Share by Players (2018-2024)
Table 20. Global Top Human Immunodeficiency Virus (HIV) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunodeficiency Virus (HIV) Therapeutics as of 2022)
Table 21. Global Human Immunodeficiency Virus (HIV) Therapeutics Industry Ranking 2021 VS 2022 VS 2024
Table 22. Global 5 Largest Players Market Share by Human Immunodeficiency Virus (HIV) Therapeutics Revenue (CR5 and HHI) & (2018-2024)
Table 23. Global Key Players of Human Immunodeficiency Virus (HIV) Therapeutics, Headquarters and Area Served
Table 24. Global Key Players of Human Immunodeficiency Virus (HIV) Therapeutics, Product and Application
Table 25. Global Key Players of Human Immunodeficiency Virus (HIV) Therapeutics, Product and Application
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 28. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Type (2018-2024)
Table 29. Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 30. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Type (2024-2034)
Table 31. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 32. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Share by Application (2018-2024)
Table 33. Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 34. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Share by Application (2024-2034)
Table 35. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 36. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2024-2034) & (US$ Million)
Table 37. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 38. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2024-2034) & (US$ Million)
Table 39. North America Human Immunodeficiency Virus (HIV) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 40. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 41. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 42. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 43. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2024-2034) & (US$ Million)
Table 44. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 45. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2024-2034) & (US$ Million)
Table 46. Europe Human Immunodeficiency Virus (HIV) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 47. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 48. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 49. China Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 50. China Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2024-2034) & (US$ Million)
Table 51. China Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 52. China Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2024-2034) & (US$ Million)
Table 53. Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 54. Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2024-2034) & (US$ Million)
Table 55. Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 56. Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2024-2034) & (US$ Million)
Table 57. Asia Human Immunodeficiency Virus (HIV) Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 58. Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 59. Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2024-2034) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2024-2034) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2024-2034) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 65. Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 67. ViiV Healthcare Company Details
Table 68. ViiV Healthcare Business Overview
Table 69. ViiV Healthcare Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 70. ViiV Healthcare Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024) & (US$ Million)
Table 71. ViiV Healthcare Recent Developments
Table 72. Mylan Company Details
Table 73. Mylan Business Overview
Table 74. Mylan Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 75. Mylan Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024) & (US$ Million)
Table 76. Mylan Recent Developments
Table 77. AbbVie Company Details
Table 78. AbbVie Business Overview
Table 79. AbbVie Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 80. AbbVie Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024) & (US$ Million)
Table 81. AbbVie Recent Developments
Table 82. Merck & Co., Inc. Company Details
Table 83. Merck & Co., Inc. Business Overview
Table 84. Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 85. Merck & Co., Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024) & (US$ Million)
Table 86. Merck & Co., Inc. Recent Developments
Table 87. Bristol-Myers Squibb Company Company Details
Table 88. Bristol-Myers Squibb Company Business Overview
Table 89. Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 90. Bristol-Myers Squibb Company Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024) & (US$ Million)
Table 91. Bristol-Myers Squibb Company Recent Developments
Table 92. Boehringer Ingelheim GmbH Company Details
Table 93. Boehringer Ingelheim GmbH Business Overview
Table 94. Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 95. Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024) & (US$ Million)
Table 96. Boehringer Ingelheim GmbH Recent Developments
Table 97. Genentech, Inc. Company Details
Table 98. Genentech, Inc. Business Overview
Table 99. Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 100. Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024) & (US$ Million)
Table 101. Genentech, Inc. Recent Developments
Table 102. Cipla, Inc. Company Details
Table 103. Cipla, Inc. Business Overview
Table 104. Cipla, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 105. Cipla, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024) & (US$ Million)
Table 106. Cipla, Inc. Recent Developments
Table 107. Boehringer Ingelheim GmbH Company Details
Table 108. Boehringer Ingelheim GmbH Business Overview
Table 109. Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 110. Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024) & (US$ Million)
Table 111. Boehringer Ingelheim GmbH Recent Developments
Table 112. Genentech, Inc. Company Details
Table 113. Genentech, Inc. Business Overview
Table 114. Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 115. Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024) & (US$ Million)
Table 116. Genentech, Inc. Recent Developments
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type: 2022 VS 2034
Figure 3. NRTIs Features
Figure 4. NNRTIs Features
Figure 5. Entry and Fusion Inhibitors Features
Figure 6. Protease Inhibitors Features
Figure 7. Integrase Inhibitors Features
Figure 8. Coreceptor Antagonists Features
Figure 9. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 10. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application: 2022 VS 2034
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Labs Case Studies
Figure 14. Human Immunodeficiency Virus (HIV) Therapeutics Report Years Considered
Figure 15. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 16. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 17. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Region: 2022 VS 2034
Figure 18. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Players in 2022
Figure 19. Global Top Human Immunodeficiency Virus (HIV) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunodeficiency Virus (HIV) Therapeutics as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Human Immunodeficiency Virus (HIV) Therapeutics Revenue in 2022
Figure 21. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2018-2034)
Figure 23. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2018-2034)
Figure 24. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Country (2018-2034)
Figure 25. United States Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Canada Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY (2018-2034) & (US$ Million)
Figure 28. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2018-2034)
Figure 29. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2018-2034)
Figure 30. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Country (2018-2034)
Figure 31. Germany Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. France Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. U.K. Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Italy Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Russia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Nordic Countries Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. China Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY (2018-2034) & (US$ Million)
Figure 38. China Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2018-2034)
Figure 39. China Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2018-2034)
Figure 40. Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY (2018-2034) & (US$ Million)
Figure 41. Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2018-2034)
Figure 42. Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2018-2034)
Figure 43. Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Region (2018-2034)
Figure 44. Japan Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. South Korea Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. China Taiwan Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Southeast Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. India Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. Australia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY (2018-2034) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2018-2034)
Figure 52. Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2018-2034)
Figure 53. Middle East, Africa, and Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Country (2018-2034)
Figure 54. Brazil Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. Mexico Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. Turkey Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 57. Saudi Arabia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 58. Israel Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 59. GCC Countries Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 60. ViiV Healthcare Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
Figure 61. Mylan Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
Figure 62. AbbVie Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
Figure 63. Merck & Co., Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
Figure 64. Bristol-Myers Squibb Company Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
Figure 65. Boehringer Ingelheim GmbH Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
Figure 66. Genentech, Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
Figure 67. Cipla, Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
Figure 68. Boehringer Ingelheim GmbH Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
Figure 69. Genentech, Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2018-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed